Infections organized by type and subtype and organ system
| . | Severity of infection . | |||
|---|---|---|---|---|
| Number of infection events (n = 47) . | Number of patients (n = 55) . | |||
| Any severity* . | High severity† . | Any severity* . | High severity† . | . |
| Any infection, n (%) | 47 (100) | 4 (9) | 29 (53) | 3 (6) |
| Bacterial infections, n (%) | 19 (40) | 3 (6) | 15 (27) | 3 (6) |
| Bacterial site,‡ n (%) | 14 (30) | 2 | 12 (22) | 2 (4) |
| Gram-positive bacteremia, n (%) | 2 (4) | 0 (0) | 2 (4) | 0 (0) |
| Gram-negative bacteremia, n (%) | 3 (6) | 1 (2) | 3 (6) | 2 (4) |
| Viral infections, n (%) | 25 (53) | 0 (0) | 18 (33) | 2 (4) |
| Respiratory virus, n (%) | 25 (53) | 0 (0) | 18 (33) | 2 (4) |
| Other, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Fungal infection, n (%) | 3 (6) | 1 (2) | 3 (6) | 1 (2) |
| Mold fungal, n (%) | 2 (4) | 1 (2) | 2 (4) | 1 (2) |
| Nonmold fungal, n (%) | 1 (2) | 0 (0) | 1 (2) | 0 (0) |
| Organ system | ||||
| Lower respiratory, n (%) | 16 (34) | 0 (0) | 14 (30) | 2 (4) |
| Upper respiratory, n (%) | 16 (34) | 0 (0) | 14 (30) | 2 (4) |
| Bloodstream, n (%) | 1 (2) | 1 (2) | 1 (2) | 1 (2) |
| GI, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| CNS, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Other,§ n (%) | 14 (30) | 3 (6) | 9 (16) | 2 (4) |
| . | Severity of infection . | |||
|---|---|---|---|---|
| Number of infection events (n = 47) . | Number of patients (n = 55) . | |||
| Any severity* . | High severity† . | Any severity* . | High severity† . | . |
| Any infection, n (%) | 47 (100) | 4 (9) | 29 (53) | 3 (6) |
| Bacterial infections, n (%) | 19 (40) | 3 (6) | 15 (27) | 3 (6) |
| Bacterial site,‡ n (%) | 14 (30) | 2 | 12 (22) | 2 (4) |
| Gram-positive bacteremia, n (%) | 2 (4) | 0 (0) | 2 (4) | 0 (0) |
| Gram-negative bacteremia, n (%) | 3 (6) | 1 (2) | 3 (6) | 2 (4) |
| Viral infections, n (%) | 25 (53) | 0 (0) | 18 (33) | 2 (4) |
| Respiratory virus, n (%) | 25 (53) | 0 (0) | 18 (33) | 2 (4) |
| Other, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Fungal infection, n (%) | 3 (6) | 1 (2) | 3 (6) | 1 (2) |
| Mold fungal, n (%) | 2 (4) | 1 (2) | 2 (4) | 1 (2) |
| Nonmold fungal, n (%) | 1 (2) | 0 (0) | 1 (2) | 0 (0) |
| Organ system | ||||
| Lower respiratory, n (%) | 16 (34) | 0 (0) | 14 (30) | 2 (4) |
| Upper respiratory, n (%) | 16 (34) | 0 (0) | 14 (30) | 2 (4) |
| Bloodstream, n (%) | 1 (2) | 1 (2) | 1 (2) | 1 (2) |
| GI, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| CNS, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Other,§ n (%) | 14 (30) | 3 (6) | 9 (16) | 2 (4) |
CNS, central nervous system; GI, gastrointestinal.
Any severity: infections that are mild, moderate, severe, life-threatening, or fatal.
High severity: infections that are severe, life-threatening, or fatal.
Site-specific bacterial infections were defined as evidence of bacterial infection by culture of a normally sterile site or by culture and evidence of tissue invasion of a nonsterile site.
Other includes skin and urinary tract, among other infections.